These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24821691)

  • 1. Introduction of vincristine mini-bags and an assessment of the subsequent risk of extravasation.
    Nurgat ZA; Smythe M; Al-Jedai A; Ewing S; Rasheed W; Belgaumi A; Ahmed SO; Ashour M; Al Agil A; Siddiqui K; Aljurf M
    J Oncol Pharm Pract; 2015 Oct; 21(5):339-47. PubMed ID: 24821691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication safety and the administration of intravenous vincristine: international survey of oncology pharmacists.
    Gilbar P; Chambers CR; Larizza M
    J Oncol Pharm Pract; 2015 Feb; 21(1):10-8. PubMed ID: 24418800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of extravasation of vinca alkaloids supplied in syringes or mini-bags.
    Gilbar PJ; Carrington CV
    J Oncol Pharm Pract; 2006 Jun; 12(2):113-8. PubMed ID: 16984750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple method to eliminate the risk of inadvertent intrathecal vincristine administration.
    Stefanou A; Dooley M
    J Clin Oncol; 2003 May; 21(10):2044; author reply 244. PubMed ID: 12743160
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing vincristine sulfate medication errors.
    Schulmeister L
    Oncol Nurs Forum; 2004 Sep; 31(5):E90-8. PubMed ID: 15378106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe vincristine use in Switzerland: Still a long way to go?
    Brühwiler LD; Schwappach DL
    J Oncol Pharm Pract; 2020 Jan; 26(1):51-59. PubMed ID: 30866715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inadvertent intrathecal administration of vincristine: has anything changed?
    Gilbar P
    J Oncol Pharm Pract; 2012 Mar; 18(1):155-7. PubMed ID: 21965437
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing vincristine administration errors.
    Jt Comm Perspect; 2005 Sep; 25(9):10-1. PubMed ID: 16515351
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevent inadvertent administration of intrathecal vincristine.
    Eisenberg S
    ONS Connect; 2009 Jan; 24(1):22. PubMed ID: 19253477
    [No Abstract]   [Full Text] [Related]  

  • 10. Accidental intrathecal injection of vincristine.
    Root T
    J Oncol Pharm Pract; 2005 Mar; 11(1):35. PubMed ID: 16460602
    [No Abstract]   [Full Text] [Related]  

  • 11. Inadvertent intrathecal administration of intravenous vincristine.
    Seger AC
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):167. PubMed ID: 20147847
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing vincristine administration errors: Does evidence support minibag infusions?
    Schulmeister L
    Clin J Oncol Nurs; 2006 Apr; 10(2):271-3. PubMed ID: 16708708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quest to eliminate intrathecal vincristine errors: a 40-year journey.
    Noble DJ; Donaldson LJ
    Qual Saf Health Care; 2010 Aug; 19(4):323-6. PubMed ID: 20211962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal vincristine: 3 fatal cases and a review of the literature.
    Hennipman B; de Vries E; Bökkerink JP; Ball LM; Veerman AJ
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):816-9. PubMed ID: 19801949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous contrast extravasation during CT: a national data registry and practice quality improvement initiative.
    Dykes TM; Bhargavan-Chatfield M; Dyer RB
    J Am Coll Radiol; 2015 Feb; 12(2):183-91. PubMed ID: 25245788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal myeloencephalopathy due to accidental intrathecal vincristin administration: a report of two cases.
    Dettmeyer R; Driever F; Becker A; Wiestler OD; Madea B
    Forensic Sci Int; 2001 Oct; 122(1):60-4. PubMed ID: 11587867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug administration error related to computerized prescribing.
    Le Garlantezec P; Aupée O; Alméras D; Lefeuvre L; Souleau B; Sgarioto A; Bohand X
    J Oncol Pharm Pract; 2010 Dec; 16(4):273-6. PubMed ID: 19833684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncology medication safety: a 3D status report 2008.
    Johnson PE; Chambers CR; Vaida AJ
    J Oncol Pharm Pract; 2008 Dec; 14(4):169-80. PubMed ID: 18818220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal consequences of a simple mistake: how can a patient be saved from inadvertent intrathecal vincristine?
    Reddy GK; Brown B; Nanda A
    Clin Neurol Neurosurg; 2011 Jan; 113(1):68-71. PubMed ID: 20846784
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing the risk of harm from intravenous potassium: a multi-factorial approach in the haematology setting.
    Barras M; Moore D; Pocock D; Sweedman M; Wilkinson C; Taylor K; Morton J
    J Oncol Pharm Pract; 2014 Oct; 20(5):323-31. PubMed ID: 24057453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.